title: Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemia.
authors.forename: C
authors.initials: C
authors.lastname: Simonelli
authors.forename: S
authors.initials: S
authors.lastname: Zanussi
authors.forename: M
authors.initials: M
authors.lastname: Comar
authors.forename: E
authors.initials: E
authors.lastname: Vaccher
authors.forename: M
authors.initials: M
authors.lastname: Giacca
authors.forename: P
authors.initials: P
authors.lastname: De Paoli
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D017493:Leukocyte Common Antigens / Q000032:analysis / Q000276:immunology; D008297:Male; D010865:Pilot Projects; D012367:RNA, Viral / Q000097:blood; D014766:Viremia / Q000188:drug therapy* / Q000276:immunology; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D007376:Interleukin-2; D012367:RNA, Viral; D015215:Zidovudine; D017493:Leukocyte Common Antigens; D016049:Didanosine